Dentsply Sirona Inc. (XRAY) Social Stream



Dentsply Sirona Inc. (XRAY): $17.87

0.52 (+3.00%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

DENTSPLY SIRONA INC (XRAY) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering XRAY.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-05 10 $79 $40 $67.111 $35.59 88.57%
2022-01-05 9 $79 $60 $70.25 $35.59 97.39%
2022-02-23 10 $79 $60 $69.333 $35.59 94.81%
2022-03-01 10 $72 $55 $64.125 $35.59 80.18%
2022-03-10 9 $72 $55 $64.125 $35.59 80.18%
2022-04-04 9 $72 $55.001 $64.125 $35.59 80.18%
2022-04-11 9 $72 $55.001 $63.875 $35.59 79.47%
2022-04-12 9 $72 $53 $63 $35.59 77.02%
2022-04-20 10 $72 $46 $60.125 $35.59 68.94%
2022-04-22 10 $67 $46 $52.333 $35.59 47.04%
2022-05-11 9 $67 $40 $49.75 $35.59 39.79%
2022-05-23 9 $51 $40 $45.125 $35.59 26.79%
2022-06-02 10 $51 $40 $45.333 $35.59 27.38%
2022-07-25 12 $51 $38 $43.636 $35.59 22.61%
2022-08-04 12 $51 $38 $43.636 $35.59 22.61%
2022-08-05 12 $51 $38 $43.2 $35.59 21.38%
2022-09-22 11 $51 $38 $43.2 $35.59 21.38%
2022-10-12 11 $51 $38 $43 $35.59 20.82%
2022-10-17 11 $51 $33 $42.5 $35.59 19.42%
2022-11-02 11 $51 $33 $42 $35.59 18.01%
2022-11-15 11 $51 $33 $40.9 $35.59 14.92%
2022-11-16 11 $48 $29 $37.9 $35.59 6.49%
2022-12-11 11 $48 $29 $37.3 $35.59 4.8%
2023-01-11 11 $48 $29 $37.6 $35.59 5.65%
2023-01-13 11 $48 $29 $37.6 $35.59 5.65%
2023-01-27 11 $48 $29 $37.9 $35.59 6.49%
2023-02-28 11 $48 $32 $38.5 $35.59 8.18%
2023-03-01 11 $48 $32 $39.3 $35.59 10.42%
2023-03-07 11 $48 $37 $41.3 $35.59 16.04%
2023-04-19 10 $47 $37 $41.222 $35.59 15.82%
2023-05-05 11 $51 $39 $44 $35.59 23.63%
2023-05-10 11 $51 $39 $44.1 $35.59 23.91%
2023-08-01 10 $51 $39 $44.1 $35.59 23.91%
2023-08-04 10 $51 $39 $44.333 $35.59 24.57%
2023-08-18 10 $51 $39 $44.2 $35.59 24.19%
2023-10-17 10 $51 $39 $43.9 $35.59 23.35%
2023-10-26 10 $51 $39 $43.5 $35.59 22.23%
2023-11-02 10 $51 $35 $42 $35.59 18.01%
2023-11-06 10 $46 $30 $36.6 $35.59 2.84%
2023-11-07 10 $46 $30 $36 $35.59 1.15%
2023-11-13 10 $46 $30 $35.7 $35.59 0.31%
2023-12-15 12 $41 $30 $34.909 $35.59 -1.91%

The Trend in the Analyst Price Target


XRAY's average price target has moved down $2.26 over the prior 46 weeks.

Over the past 49 weeks, XRAY's average upside potential has been 13%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-08 11 48 32 38.500 38.00 1.32%
2023-08-01 10 51 39 44.100 41.37 6.6%
2023-08-04 10 51 39 44.200 39.29 12.5%
2023-10-20 10 51 39 43.500 31.85 36.58%
2023-12-15 12 46 30 35.636 34.38 3.65%

XRAY Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.23 3 2 6 0 0 11

The Trend in the Broker Recommendations


XRAY's average broker recommendation rating worsened by 0.04 over the prior 46 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of Healthcare stocks, DENTSPLY SIRONA INC's variance in analysts' estimates is lower than -1289.39% of them.
  • To contextualize these metrics, consider that out of stocks in the large market cap category, DENTSPLY SIRONA INC's number of analysts covering the stock is greater than 1397.25% of them.
  • To contextualize these metrics, consider that out of stocks in the large market cap category, DENTSPLY SIRONA INC's upside potential (average analyst target price relative to current price) is higher than 3324.77% of them.
  • XRAY has a higher average analyst price target than 1454.86% of stocks in the large market cap category.

In the Medical Equipment industry, ALC, COO, and INGN are the three stocks most similar to DENTSPLY SIRONA INC regarding the price target and analyst recommendation information presented here.

Is XRAY a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!